Hormone therapy including hormone replacement therapy (HRT), oral contraceptive pills (OCPs), and testosterone is commonly used. OCPs and HRT are associated with an increased risk of venous thromboembolism (VTE). Perioperative consultants may be asked to provide recommendations for the risks and/or management of these medications perioperatively. This chapter provides an overview of risks of use of hormone therapy around the time of surgery and suggestions for management.
KeywordsHormone replacement therapy Estrogen Testosterone Venous thromboembolism Coronary artery disease
- 8.de Bastos M, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014;(3):CD010813.Google Scholar